Search - tctmd.com

Displaying 781 - 798 of 798

Sort: Relevancy | Date

News Daily News

TAVI Appears Safe for Patients with Small Annuli

August 22, 2011

News Daily News

PFO-Stroke Link Takes Another Hit

August 11, 2011

News Daily News

ROCKET AF Published: Rivaroxaban Matches Warfarin in Treating A-Fib Patients

August 10, 2011

News Daily News

Apixaban Increases Major Bleeding in High-Risk ACS Patients

July 25, 2011

News Daily News

Commentary Authors Urge Improvements to Device Approval Process

July 20, 2011

News Daily News

ARISTOTLE Makes Its Case: Apixaban Noninferior to Warfarin in A-fib

June 24, 2011

News Daily News

Renal Dysfunction Takes Toll on Carotid Revascularization Outcomes

June 22, 2011

News Daily News

PARTNER Cohort A Published: Surgical Candidates Obtain Similar 1-Year Survival with TAVI, Surgery

June 07, 2011

News Daily News

Dabigatran Cost-Effective Only for A-Fib Patients at High Stroke Risk

June 03, 2011

News Daily News

Guideline-Based Treatments Linked to Improved Survival for STEMI Patients

April 27, 2011

News Daily News

Cerebral Atherosclerosis Predicts Post-CABG Stroke Risk

April 25, 2011

News Daily News

Elderly STEMI Patients Face Poorer Outcomes After Primary PCI

April 20, 2011

News Daily News

Dabigatran Recommended as Alternative to Warfarin in A-fib Patients

February 13, 2011

News Daily News

New Anticoagulant More Effective Than Aspirin at Stroke Prevention in A-fib

February 09, 2011

News Daily News

Randomized Trial Clouds Debate Over DES, CABG in Left Main Disease

January 23, 2011

News Daily News

Ongoing Experience Improves Safety for LAA Closure with Watchman Device

January 20, 2011

News Daily News

NEJM Letters Take on PARTNER Trial

January 11, 2011

News Daily News

Dabigatran an Alternative to Warfarin for Stroke Prevention in A-Fib Patients

September 03, 2009

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.